Stage IIB Squamous Cell Lung Carcinoma AJCC v7 Recruiting Phase 3 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0090822 (Stage IIB Squamous Cell Lung Carcinoma AJCC v7)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs